Suppr超能文献

一种结合非线性杂交链式反应和脱氧核酶用于检测微小RNA的自催化平台。

An Autocatalytic Platform Combining a Nonlinear Hybridization Chain Reaction and DNAzyme to Detect microRNA.

作者信息

Zhang Hongbo, Cao Xiuen, Zhu Qubo

机构信息

Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.

出版信息

Bio Protoc. 2024 Dec 20;14(24):e5134. doi: 10.21769/BioProtoc.5134.

Abstract

MicroRNAs (miRNAs) are small, non-coding RNAs that play pivotal roles in gene regulation; they are increasingly recognized as vital biomarkers for various diseases, notably cancer. Conventional methods for miRNA detection, such as quantitative PCR and microarray analysis, often entail intricate sample preparation and lack the requisite sensitivity to detect low-abundance miRNAs like miRNA-21. This protocol presents an innovative approach that combines branched hybridization chain reaction (bHCR) with DNAzyme technology for the precise detection of miRNA-21. The bHCR amplifies the target signal through a branched structure, while the DNAzyme boosts detection sensitivity through catalytic cleavage, enabling swift and specific identification of miRNA-21. This dual amplification strategy offers a highly sensitive, specific, and rapid alternative to traditional techniques, making it particularly well-suited for early-stage disease diagnosis. Key features • This protocol enables a sensitive detection of miRNA-21. • The technique employs an isothermal, enzyme-free bHCR process that can be carried out using standard laboratory equipment, eliminating the necessity for specialized instruments. • The entire protocol can be finalized in less than five hours, offering a swift and effective approach for high-throughput miRNA detection. • Minimal input RNA is needed for the protocol, and the sample preparation steps are straightforward.

摘要

微小RNA(miRNA)是一类小的非编码RNA,在基因调控中发挥关键作用;它们越来越被认为是各种疾病(尤其是癌症)的重要生物标志物。传统的miRNA检测方法,如定量PCR和微阵列分析,通常需要复杂的样品制备,并且缺乏检测低丰度miRNA(如miRNA-21)所需的灵敏度。本方案提出了一种创新方法,将分支杂交链式反应(bHCR)与脱氧核酶技术相结合,用于精确检测miRNA-21。bHCR通过分支结构放大目标信号,而脱氧核酶通过催化切割提高检测灵敏度,能够快速、特异性地识别miRNA-21。这种双重扩增策略为传统技术提供了一种高度灵敏、特异且快速的替代方法,使其特别适用于疾病的早期诊断。关键特性 • 本方案能够灵敏地检测miRNA-21。 • 该技术采用等温、无酶的bHCR过程,可使用标准实验室设备进行,无需专门仪器。 • 整个方案可在不到五小时内完成,为高通量miRNA检测提供了一种快速有效的方法。 • 该方案所需的RNA输入量极少,样品制备步骤简单。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f22/11669909/497cf9d05db5/BioProtoc-14-24-5134-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验